Global Isoxazoline Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
1 Market Overview
- 1.1 Isoxazoline Drugs Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Overview: Global Isoxazoline Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
- 1.2.2 Fluralaner
- 1.2.3 Afoxolaner
- 1.2.4 Sarolaner
- 1.2.5 Lotilaner
- 1.2.6 Others
- 1.3 Market Analysis by Application
- 1.3.1 Overview: Global Isoxazoline Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
- 1.3.2 Dog
- 1.3.3 Cat
- 1.3.4 Others
- 1.4 Global Isoxazoline Drugs Market Size & Forecast
- 1.4.1 Global Isoxazoline Drugs Sales in Value (2017 & 2021 & 2028)
- 1.4.2 Global Isoxazoline Drugs Sales in Volume (2017-2028)
- 1.4.3 Global Isoxazoline Drugs Price (2017-2028)
- 1.5 Global Isoxazoline Drugs Production Capacity Analysis
- 1.5.1 Global Isoxazoline Drugs Total Production Capacity (2017-2028)
- 1.5.2 Global Isoxazoline Drugs Production Capacity by Geographic Region
- 1.6 Market Drivers, Restraints and Trends
- 1.6.1 Isoxazoline Drugs Market Drivers
- 1.6.2 Isoxazoline Drugs Market Restraints
- 1.6.3 Isoxazoline Drugs Trends Analysis
2 Manufacturers Profiles
- 2.1 Merck Animal Health Inc.
- 2.1.1 Merck Animal Health Inc. Details
- 2.1.2 Merck Animal Health Inc. Major Business
- 2.1.3 Merck Animal Health Inc. Isoxazoline Drugs Product and Services
- 2.1.4 Merck Animal Health Inc. Isoxazoline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.2 Elanco Animal Health Incorporated
- 2.2.1 Elanco Animal Health Incorporated Details
- 2.2.2 Elanco Animal Health Incorporated Major Business
- 2.2.3 Elanco Animal Health Incorporated Isoxazoline Drugs Product and Services
- 2.2.4 Elanco Animal Health Incorporated Isoxazoline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.3 Boehringer Ingelheim International GmbH
- 2.3.1 Boehringer Ingelheim International GmbH Details
- 2.3.2 Boehringer Ingelheim International GmbH Major Business
- 2.3.3 Boehringer Ingelheim International GmbH Isoxazoline Drugs Product and Services
- 2.3.4 Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.4 Zoetis Inc
- 2.4.1 Zoetis Inc Details
- 2.4.2 Zoetis Inc Major Business
- 2.4.3 Zoetis Inc Isoxazoline Drugs Product and Services
- 2.4.4 Zoetis Inc Isoxazoline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
- 2.5 Nissan Chemical Corporation
- 2.5.1 Nissan Chemical Corporation Details
- 2.5.2 Nissan Chemical Corporation Major Business
- 2.5.3 Nissan Chemical Corporation Isoxazoline Drugs Product and Services
- 2.5.4 Nissan Chemical Corporation Isoxazoline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Isoxazoline Drugs Breakdown Data by Manufacturer
- 3.1 Global Isoxazoline Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
- 3.2 Global Isoxazoline Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
- 3.3 Key Manufacturer Market Position in Isoxazoline Drugs
- 3.4 Market Concentration Rate
- 3.4.1 Top 3 Isoxazoline Drugs Manufacturer Market Share in 2021
- 3.4.2 Top 6 Isoxazoline Drugs Manufacturer Market Share in 2021
- 3.5 Global Isoxazoline Drugs Production Capacity by Company: 2021 VS 2022
- 3.6 Manufacturer by Geography: Head Office and Isoxazoline Drugs Production Site
- 3.7 New Entrant and Capacity Expansion Plans
- 3.8 Mergers & Acquisitions
4 Market Analysis by Region
- 4.1 Global Isoxazoline Drugs Market Size by Region
- 4.1.1 Global Isoxazoline Drugs Sales in Volume by Region (2017-2028)
- 4.1.2 Global Isoxazoline Drugs Revenue by Region (2017-2028)
- 4.2 North America Isoxazoline Drugs Revenue (2017-2028)
- 4.3 Europe Isoxazoline Drugs Revenue (2017-2028)
- 4.4 Asia-Pacific Isoxazoline Drugs Revenue (2017-2028)
- 4.5 South America Isoxazoline Drugs Revenue (2017-2028)
- 4.6 Middle East and Africa Isoxazoline Drugs Revenue (2017-2028)
5 Market Segment by Type
- 5.1 Global Isoxazoline Drugs Sales in Volume by Type (2017-2028)
- 5.2 Global Isoxazoline Drugs Revenue by Type (2017-2028)
- 5.3 Global Isoxazoline Drugs Price by Type (2017-2028)
6 Market Segment by Application
- 6.1 Global Isoxazoline Drugs Sales in Volume by Application (2017-2028)
- 6.2 Global Isoxazoline Drugs Revenue by Application (2017-2028)
- 6.3 Global Isoxazoline Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
- 7.1 North America Isoxazoline Drugs Sales by Type (2017-2028)
- 7.2 North America Isoxazoline Drugs Sales by Application (2017-2028)
- 7.3 North America Isoxazoline Drugs Market Size by Country
- 7.3.1 North America Isoxazoline Drugs Sales in Volume by Country (2017-2028)
- 7.3.2 North America Isoxazoline Drugs Revenue by Country (2017-2028)
- 7.3.3 United States Market Size and Forecast (2017-2028)
- 7.3.4 Canada Market Size and Forecast (2017-2028)
- 7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
- 8.1 Europe Isoxazoline Drugs Sales by Type (2017-2028)
- 8.2 Europe Isoxazoline Drugs Sales by Application (2017-2028)
- 8.3 Europe Isoxazoline Drugs Market Size by Country
- 8.3.1 Europe Isoxazoline Drugs Sales in Volume by Country (2017-2028)
- 8.3.2 Europe Isoxazoline Drugs Revenue by Country (2017-2028)
- 8.3.3 Germany Market Size and Forecast (2017-2028)
- 8.3.4 France Market Size and Forecast (2017-2028)
- 8.3.5 United Kingdom Market Size and Forecast (2017-2028)
- 8.3.6 Russia Market Size and Forecast (2017-2028)
- 8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
- 9.1 Asia-Pacific Isoxazoline Drugs Sales by Type (2017-2028)
- 9.2 Asia-Pacific Isoxazoline Drugs Sales by Application (2017-2028)
- 9.3 Asia-Pacific Isoxazoline Drugs Market Size by Region
- 9.3.1 Asia-Pacific Isoxazoline Drugs Sales in Volume by Region (2017-2028)
- 9.3.2 Asia-Pacific Isoxazoline Drugs Revenue by Region (2017-2028)
- 9.3.3 China Market Size and Forecast (2017-2028)
- 9.3.4 Japan Market Size and Forecast (2017-2028)
- 9.3.5 Korea Market Size and Forecast (2017-2028)
- 9.3.6 India Market Size and Forecast (2017-2028)
- 9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
- 9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
- 10.1 South America Isoxazoline Drugs Sales by Type (2017-2028)
- 10.2 South America Isoxazoline Drugs Sales by Application (2017-2028)
- 10.3 South America Isoxazoline Drugs Market Size by Country
- 10.3.1 South America Isoxazoline Drugs Sales in Volume by Country (2017-2028)
- 10.3.2 South America Isoxazoline Drugs Revenue by Country (2017-2028)
- 10.3.3 Brazil Market Size and Forecast (2017-2028)
- 10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
- 11.1 Middle East & Africa Isoxazoline Drugs Sales by Type (2017-2028)
- 11.2 Middle East & Africa Isoxazoline Drugs Sales by Application (2017-2028)
- 11.3 Middle East & Africa Isoxazoline Drugs Market Size by Country
- 11.3.1 Middle East & Africa Isoxazoline Drugs Sales in Volume by Country (2017-2028)
- 11.3.2 Middle East & Africa Isoxazoline Drugs Revenue by Country (2017-2028)
- 11.3.3 Turkey Market Size and Forecast (2017-2028)
- 11.3.4 Egypt Market Size and Forecast (2017-2028)
- 11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
- 11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
- 12.1 Raw Material of Isoxazoline Drugs and Key Manufacturers
- 12.2 Manufacturing Costs Percentage of Isoxazoline Drugs
- 12.3 Isoxazoline Drugs Production Process
- 12.4 Isoxazoline Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.2 Isoxazoline Drugs Typical Distributors
- 13.3 Isoxazoline Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
- 15.2 Research Process and Data Source
The Isoxazoline Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Isoxazoline Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Dog accounting for % of the Isoxazoline Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Fluralaner segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Isoxazoline Drugs include Merck Animal Health Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Zoetis Inc, and Nissan Chemical Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Isoxazoline Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fluralaner
Afoxolaner
Sarolaner
Lotilaner
Others
Market segment by Application can be divided into
Dog
Cat
Others
The key market players for global Isoxazoline Drugs market are listed below:
Merck Animal Health Inc.
Elanco Animal Health Incorporated
Boehringer Ingelheim International GmbH
Zoetis Inc
Nissan Chemical Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Isoxazoline Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Isoxazoline Drugs, with price, sales, revenue and global market share of Isoxazoline Drugs from 2019 to 2022.
Chapter 3, the Isoxazoline Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Isoxazoline Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Isoxazoline Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Isoxazoline Drugs.
Chapter 13, 14, and 15, to describe Isoxazoline Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.